Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Debt Ratio (2016 - 2023)

Marker Therapeutics (MRKR) has disclosed Debt Ratio for 7 consecutive years, with 0.0 as the latest value for Q1 2023.

  • Quarterly Debt Ratio changed N/A to 0.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 0.0 through Mar 2023, changed N/A year-over-year, with the annual reading at 0.07 for FY2022, N/A changed from the prior year.
  • Debt Ratio for Q1 2023 was 0.0 at Marker Therapeutics, down from 0.07 in the prior quarter.
  • The five-year high for Debt Ratio was 0.15 in Q2 2022, with the low at 0.0 in Q4 2019.
  • Average Debt Ratio over 3 years is 0.04, with a median of 0.0 recorded in 2019.
  • Peak annual rise in Debt Ratio hit 15.19% in 2019, while the deepest fall reached 93.65% in 2019.
  • Over 3 years, Debt Ratio stood at 0.0 in 2019, then surged by 10761.17% to 0.07 in 2022, then plummeted by 95.2% to 0.0 in 2023.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.0, 0.07, and 0.12 for Q1 2023, Q4 2022, and Q3 2022 respectively.